Regulatory Intelligence: Knowing What Changed Before It Costs You

Regulatory intelligence is the practice of monitoring what regulators publish, deciding what applies to your products, and getting that to the people who act on it.

Most organisations do the first part. The value is in the second and third.

The sources

Primary, and authoritative:

• The Federal Register for proposed and final rules.
• eCFR for the regulation as it currently stands.
• FDA guidance documents, draft and final, plus the guidance agenda.
• ICH guidelines and their implementation status by region.
• EMA guidelines, and the EURD list for periodic safety reporting periodicity.
• Advisory committee materials and meeting minutes.

Precedent, which is where the useful specifics live:

• Warning letters and inspection classifications, which show what is actually being cited rather than what the rule says.
• Complete Response Letters, where FDA sets out why an application was not approved.
• Approval packages and review memoranda in Drugs@FDA.
• 510(k) clearances and De Novo decision summaries.

A guidance tells you the standard. Precedent tells you how it is applied, and the two are not the same document.

The hard part is relevance, not collection

Collecting is solved. Subscribe to enough feeds and you will drown.

The work is deciding, for each item: does this apply to any of our products, and if so, what has to change and by when. That requires knowing your own portfolio in enough detail to answer it, which is why regulatory intelligence sitting outside the teams who own the dossiers tends to produce newsletters nobody acts on.

The output that matters is not a summary. It is a specific statement that a named product needs a named change on a date, routed to whoever owns it.

Why it decays

An assessment is correct on the day it is made, against the portfolio as it was then. New markets, acquired products and changed suppliers all silently invalidate previous conclusions, and nothing announces this.

The failure is quiet and it is the normal one: an obligation was assessed as not applying to a product you did not own at the time.